News Category
Onco-Innovations has signed a non-binding LOI to potentially acquire exclusive rights to Ifowonco's oral small-molecule LAG-3 inhibitor program, which...
A new study reveals that nearly 80% of young adults have CKM syndrome, with more advanced stages linked to early arterial injury, emphasizing the need...
Quantum BioPharma's Lucid-MS offers a novel approach to treating multiple sclerosis by targeting myelin degradation and smoldering lesions, potentiall...
A new mathematical study offers a potential explanation for why melanoma immunotherapy fails in some patients, which could lead to improved treatment ...
Quantum BioPharma's Lucid-MS, a novel myelin-protecting therapy for multiple sclerosis, has received FDA clearance for phase 2 trials, potentially shi...
VERAXA Biotech's collaboration with AI firm Ardigen aims to use artificial intelligence to optimize its oncology pipeline, potentially reducing develo...
Scientists have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, potential...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the Democratic Republic of Congo, p...
The 20th Annual Sickle Cell Disease Educational Summit, hosted by Cayenne Wellness Center, commemorates two decades of progress in sickle cell care wh...
Helix BioPharma has appointed Dr. Markus Loeffler as Chief Medical Officer to lead the clinical development of L-DOS47 and LEUMUNA, marking a strategi...
The summit aims to address the unique challenges faced by Hispanic and Latino individuals with sickle cell disease, emphasizing culturally relevant ed...
The Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer are investing $400,000 in two promising early-car...
A comprehensive review provides a structured approach to surgical management of necrotizing enterocolitis in premature infants, emphasizing bowel pres...
Maria Cristina Swiman's memoir chronicles a mother's harrowing journey across Brazil, Europe, and the US to reunite with her abducted daughter, highli...
Helix BioPharma's board reshuffle, with CEO Thomas Mehrling appointed as director following Janusz Grabski's resignation, aligns governance with strat...
Onco-Innovations is building the scientific foundation for its precision oncology drug ONC010, a nanoparticle-encapsulated PNKP inhibitor, through man...
Researchers at the University of Manchester discovered that a subset of immune cells, previously overlooked, plays a crucial role in orchestrating and...
Lantern Pharma's Q2 2026 results show significant pipeline progress and strategic moves, including the establishment of Open Medicine AI as a separate...
NeOnc Technologies' NEO100 met its primary endpoint in a Phase 2a trial for recurrent brain cancer, showing significant survival benefits and tolerabi...
GeoVax offers its MVA-based hemorrhagic fever vaccine expertise and candidates to aid the global response to the fast-growing Bundibugyo Ebola outbrea...
Kyle Brown's participation in ALS Arizona's Bite Nite gala highlights the law firm's commitment to supporting families affected by ALS through legal a...
NanoViricides has received approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more accessibl...
New research from the University of Virginia suggests focused ultrasound could make brain cancer treatments more effective and less harmful, potential...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in TNBC models, supporting its Phase 1/2 t...
A new narrative review in the World Journal of Pediatric Surgery provides a comprehensive framework for risk-adapted neuroblastoma care, emphasizing t...
Quantum BioPharma advances its two-pronged approach to neurological health, with Lucid-MS targeting myelin repair in multiple sclerosis and unbuzzd ad...
A Spanish patient initially treated for brain cancer was found to have pork tapeworm cysts, underscoring the importance of proper food preparation and...
VERAXA Biotech's VXA-222 bispecific antibody-drug conjugate program has moved into the next development stage, supported by an expanded patent portfol...
The Keep A Breast Foundation's 2026 High Desert Collection transforms chest casts into artworks, launching a community fundraising campaign to promote...
A new liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatment...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning the program for a ...
Onco-Innovations is leveraging a multi-pronged approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to progress its l...
Researchers at Nagoya University found that the immune protein C3, when produced within tumors, may boost the effectiveness of immunotherapy, offering...
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed paper, isolates over 99% pure tumor-derived DNA, potentially addressing a $23 bil...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, solidify...
The American Heart Association's recognition of more than 3,000 hospitals underscores the growing commitment to evidence-based care, which is crucial ...
The US has recorded 2,371 measles cases this year, the highest in three decades, prompting health officials to intensify contact tracing and vaccinati...
Oncotelic Therapeutics will present at the OTCQB Virtual Investor Conference, highlighting its progress in cancer drug development, including a Phase ...
Recent independent research suggesting cross-reactive immune responses from licensed Ebola vaccines underscores the potential for broad-spectrum filov...
Amber Dermatology, founded by Dr. Alyssa Miceli, opens in Trumbull, offering a patient-centered approach to medical, surgical, pediatric, and cosmetic...
Experts warn that climate change is accelerating the spread of infectious diseases, yet policymakers are not addressing the threat adequately, prompti...
VERAXA Biotech's appointment of Dr. Christoph Erkel as CSO underscores its commitment to advancing the BiTAC® platform toward clinical development, wi...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, intending to use the proceeds to...
Dr. Lee Newcomer, a nationally recognized health care policy expert and former Chief Medical Officer of UnitedHealthcare, has signed with Creative Man...
A new preclinical study suggests an experimental therapy containing vitamin B12 could halt the progression of glioblastoma multiforme, the deadliest b...
VolitionRx announced a growing body of clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis, with studies showing it can disting...
VERAXA Biotech's expanded patent portfolio, including new filings for BiTAC-TCE and BiTAC-ADC platforms, strengthens its position in developing safer,...
VERAXA Biotech (NASDAQ: VRXA) names antibody therapeutics expert Dr. Christoph Erkel as CSO to advance its proprietary BiTAC(R) platform and prepare l...
